Strategic Assessment for Portfolio Expansion of an Animal Health Pharma Company
A global animal health pharmaceutical client engaged Stellarix to gain end-to-end visibility into the nsMRA landscape relevant to feline chronic kidney disease (CKD). Our actionable intelligence enabled the firm to strengthen its competitive position by expanding its portfolio, streamlining partner shortlisting & prioritizing, and identifying market gaps. Client Background: A global animal health pharmaceutical company […]